PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.0%)
IDR 3580.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 161.93 Billion IDR | -42.25% |
| 2022 | 280.4 Billion IDR | -18.06% |
| 2021 | 342.22 Billion IDR | 7.88% |
| 2020 | 317.21 Billion IDR | 3.31% |
| 2019 | 307.04 Billion IDR | -58.78% |
| 2018 | 744.83 Billion IDR | 221.65% |
| 2017 | 231.56 Billion IDR | 43.6% |
| 2016 | 161.26 Billion IDR | -4.07% |
| 2015 | 168.1 Billion IDR | 3.19% |
| 2014 | 162.9 Billion IDR | -11.81% |
| 2013 | 184.72 Billion IDR | 20.98% |
| 2012 | 152.68 Billion IDR | 69.27% |
| 2011 | 90.2 Billion IDR | 25.72% |
| 2010 | 71.75 Billion IDR | -10.07% |
| 2009 | 79.78 Billion IDR | 67.13% |
| 2008 | 47.74 Billion IDR | -6.08% |
| 2007 | 50.82 Billion IDR | 7.87% |
| 2006 | 47.11 Billion IDR | 25.13% |
| 2005 | 37.65 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 187.33 Billion IDR | -30.53% |
| 2024 Q1 | 247.8 Billion IDR | 53.03% |
| 2024 Q2 | 269.65 Billion IDR | 8.82% |
| 2023 Q3 | 183.46 Billion IDR | -3.04% |
| 2023 Q1 | 235.08 Billion IDR | -16.16% |
| 2023 FY | 161.93 Billion IDR | -42.25% |
| 2023 Q4 | 161.93 Billion IDR | -11.74% |
| 2023 Q2 | 189.22 Billion IDR | -19.51% |
| 2022 FY | 280.4 Billion IDR | -18.06% |
| 2022 Q1 | 313.84 Billion IDR | -8.29% |
| 2022 Q4 | 280.4 Billion IDR | 24.9% |
| 2022 Q2 | 288.51 Billion IDR | -8.07% |
| 2022 Q3 | 224.5 Billion IDR | -22.19% |
| 2021 Q2 | 245.92 Billion IDR | 10.98% |
| 2021 FY | 342.22 Billion IDR | 7.88% |
| 2021 Q4 | 342.22 Billion IDR | 37.34% |
| 2021 Q1 | 221.6 Billion IDR | -30.14% |
| 2021 Q3 | 249.18 Billion IDR | 1.32% |
| 2020 Q3 | 333.87 Billion IDR | 1.68% |
| 2020 Q1 | 335.05 Billion IDR | 9.12% |
| 2020 Q2 | 328.35 Billion IDR | -2.0% |
| 2020 FY | 317.21 Billion IDR | 3.31% |
| 2020 Q4 | 317.21 Billion IDR | -4.99% |
| 2019 Q2 | 324.38 Billion IDR | -55.14% |
| 2019 Q3 | 265.54 Billion IDR | -18.14% |
| 2019 Q4 | 307.04 Billion IDR | 15.63% |
| 2019 Q1 | 723.09 Billion IDR | -2.92% |
| 2019 FY | 307.04 Billion IDR | -58.78% |
| 2018 Q2 | 356.78 Billion IDR | 68.99% |
| 2018 FY | 744.83 Billion IDR | 221.65% |
| 2018 Q4 | 744.83 Billion IDR | 197.24% |
| 2018 Q3 | 250.58 Billion IDR | -29.77% |
| 2018 Q1 | 211.13 Billion IDR | -8.83% |
| 2017 Q2 | 242 Billion IDR | 15.4% |
| 2017 Q1 | 209.71 Billion IDR | 30.04% |
| 2017 FY | 231.56 Billion IDR | 43.6% |
| 2017 Q4 | 231.56 Billion IDR | -12.74% |
| 2017 Q3 | 265.39 Billion IDR | 9.66% |
| 2016 Q3 | 158.19 Billion IDR | -25.07% |
| 2016 FY | 161.26 Billion IDR | -4.07% |
| 2016 Q4 | 161.26 Billion IDR | 1.94% |
| 2016 Q2 | 211.13 Billion IDR | -29.83% |
| 2016 Q1 | 300.9 Billion IDR | 79.0% |
| 2015 FY | 168.1 Billion IDR | 3.19% |
| 2015 Q1 | 135.24 Billion IDR | -16.98% |
| 2015 Q2 | 137.85 Billion IDR | 1.94% |
| 2015 Q3 | 122.31 Billion IDR | -11.28% |
| 2015 Q4 | 168.1 Billion IDR | 37.44% |
| 2014 Q3 | 142.86 Billion IDR | -11.59% |
| 2014 FY | 162.9 Billion IDR | -11.81% |
| 2014 Q2 | 161.58 Billion IDR | -54.96% |
| 2014 Q4 | 162.9 Billion IDR | 14.03% |
| 2014 Q1 | 358.75 Billion IDR | 94.21% |
| 2013 FY | 184.72 Billion IDR | 20.98% |
| 2013 Q2 | 173.09 Billion IDR | -30.52% |
| 2013 Q1 | 249.13 Billion IDR | 63.17% |
| 2013 Q4 | 184.72 Billion IDR | -2.09% |
| 2013 Q3 | 188.67 Billion IDR | 9.01% |
| 2012 Q1 | 89.78 Billion IDR | -0.46% |
| 2012 FY | 152.68 Billion IDR | 69.27% |
| 2012 Q4 | 152.68 Billion IDR | -14.63% |
| 2012 Q3 | 178.85 Billion IDR | 85.83% |
| 2012 Q2 | 96.24 Billion IDR | 7.19% |
| 2011 Q4 | 90.2 Billion IDR | 0.0% |
| 2011 Q1 | 85.07 Billion IDR | 18.57% |
| 2011 FY | 90.2 Billion IDR | 25.72% |
| 2010 Q4 | 71.75 Billion IDR | -53.67% |
| 2010 FY | 71.75 Billion IDR | -10.07% |
| 2010 Q1 | 62.87 Billion IDR | -21.19% |
| 2010 Q3 | 154.86 Billion IDR | 0.0% |
| 2009 Q4 | 79.78 Billion IDR | 0.0% |
| 2009 FY | 79.78 Billion IDR | 67.13% |
| 2008 FY | 47.74 Billion IDR | -6.08% |
| 2007 FY | 50.82 Billion IDR | 7.87% |
| 2006 FY | 47.11 Billion IDR | 25.13% |
| 2005 FY | 37.65 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 639.05 Billion IDR | 74.66% |
| PT Phapros, Tbk | 995.56 Billion IDR | 83.734% |
| PT Pyridam Farma Tbk | 1164.17 Billion IDR | 86.09% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 504.76 Billion IDR | 67.919% |
| PT Tempo Scan Pacific Tbk | 3250.09 Billion IDR | 95.018% |